1Sousa JE,Costa MA,Abizaid AC,et al.Sustained suppression of neointimal proliferation by sirolimus-eluting stents:one year angiographic and intravascular ultrasound follow-up[J].Circulation,2001,104(17):2007 -2011.
2Sousa JE,Costa MA,Abizaid A,et al.Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus eluting stents[J].Circulation,2005,111:2326-2329.
3Serruys PW,Degertekin M,Tanabe K,et al.Intravascular ultrasound finding in the multicenter,randomized,double-blind RAVEL(randomized study with the sirolimus-eluting velocity balloonexpandable stent in the treatment of patients with de novo native coronary artery lesions trial[J].Circulation,2002,106 (7):798 -803.
4Rahel BM,Suttop M J,Laarman GJ,et al.Primary stenting of occluded native coronary arteries (RRISON) study[J].Am Heart J,2004,147:e22.
5Ge L,Iakovou I,Cosgrave J,et al.Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions[J].Eur Heart J,2005,26:1056-1062.
7Tsagalou E,Stancovic G,Iakovou I,et al.Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents[J].Am J Cardiol,2006,97 (2):187-191.
8Chieffo A,Stankovic G,Bonizzoni E,et al.Early and mid-term resuits of drug-eluting stent implantation in unprotected left main[J].Circulation,2005,111 (6):791-795.
9Moses JW,Mehran R,Nikolsky E,et al.Outcomes with the paclitaxel-eluting stent inpatients with acute coronary syndromes:analysis from the TAXUS-Ⅳ trial[J].J Am Coll Cardiol,2005,45 (8):1165-1171.
1Gallo R,Padurean A,Jayaraman T,et al.Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulator.Circulation,1999,99(16):2164-2170.
2Steven O,Andrew R.The development of rapamycin and its application to stent restenosis.Circulation,2001,104(8):852-855.
3Sousa JE,Serruys PW,Costa MA.New frontiers in cardiology:drug-eluting stent:part Ⅰ.Circulation,2003,107(17):2274-2279.
4Sousa JE,Serruys PW,Costa MA.New frontiers in cardiology:drug-eluting stent:part Ⅱ.Circulation,2003,107(18):2383-2389.
5Sousa JE,Costa MA,Abizaid AC,et al.Sustained suppression of neointimal proliferation by sirolimus-eluting stent:one-year angiographic and intravascular ultrasound follow-up.Circulation,2001,104(17):2007-2011.
6Lemos PA,Saia F,Hofma SH,et al.Short-and long-term clinical benefit of sirolimus-euting stents compared to conventional bare stents for patients with acute myocardial infarction.J Am Coll Cardiol,2004,43(4):704-708.
7Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 2004,109:190-195.
8Moreno R, Fernandez C, Alfonso F, et al. Thrombosis after drug-eluting vs bare-metal stent implantation: a meta-analysis from 10 randomized trials including 5030 patients. Circulation, 2004,110:III-687. Abstract 3181.
9Lotan C,Rozenman Y,Hendler A,et al.Stents in total occlusion for restenosis prevention.The multicentre randomized STOP study.The Israeli Working Group for Interventional Cardiology.Eur Heart J,2000,21:1960-1966.
10Rahel BM,Suttorp M J,Laarman GJ,et al.Primary stenting of occluded native coronary arteries:final results of the primary stenting of occluded native coronary arteries (PRISON) study.Am Heart J,2004,147:e22.
7Serruys P W, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group[J]. N Engl J Med,1994, 331(8):489-95.
8Fischman D L, Leon M B, Balm D S, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease[J]. N Engl J Meal,1994,331: 496-501.
9Schwertner HA,Jackson WG,Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J].Clinical Chemistry,1994,(01):18-23.
10Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease[J].Clinical Chemistry,2000,(11):1723-1727.
